Drug intelligence / Profile preview

Supracal

Development stage: Unknown
Lead developer: Pharmed
Modality: Small Molecules
Administration: Oral

Overview

Supracal is a branded generic nutraceutical marketed by Pharmed Limited. It is a calcium supplement primarily composed of calcium citrate, vitamin D3 (cholecalciferol), and essential minerals. Calcium citrate is utilized for its high bioavailability in maintaining bone mineralization and calcium homeostasis. The product is indicated for general health and musculoskeletal support, including the management of low-back pain, general weakness associated with calcium deficiency, and as a routine supplement during pregnancy and lactation.

Brand names: Supracal
Other names: calcium citrate + vitamin D3 + minerals

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Supracal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supracal.

Explore the full profile